Inrebic
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.inrebic.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Inrebic
Impact Biomedicines, a Bristol Myers Squibb company, specializes in the treatment of myelofibrosis with its prescription medication INREBIC® (fedratinib). This medication is designed for adults diagnosed with intermediate-2 or high-risk myelofibrosis, offering an essential treatment option for this condition. The company provides extensive resources and support for healthcare professionals and patients, including prescribing information and safety guidance. Despite not being approved for children, INREBIC aims to improve the quality of life for adult patients managing myelofibrosis.Explore more
Popular SearchesInrebicSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Inrebic your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Inrebic recently announced quarterly report
Product Launch: Get notified when Inrebic launches new products
Click to see if Inrebic had a recent Job posting/layoffs
Inrebic, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Inrebic
Funding: Get notified immidiatlly once Inrebic has new funding data
Check if Inrebic has recently received funding, and reach out quickly before it becomes old news!
Check out if Inrebic is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Inrebic as Masked Content
Find more new buyers
Compare Similar Companies to Inrebic
Compare insights from companies similar to Inrebic, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Company Profile Activity
Activity Insights
Inrebic is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Inrebic is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Inrebic.
Inrebic Tech Stack
A closer look at the technologies used by Inrebic
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Inrebic
Sign Up For FreeTo access detailed company insights
Impact Biomedicines, a Bristol Myers Squibb company, specializes in the treatment of myelofibrosis with its prescription medication INREBIC® (fedratinib). This medication is designed for adults diagnosed with intermediate-2 or high-risk myelofibrosis, offering an essential treatment option for this condition. The company provides extensive resource... Read More
